At an international conference, researchers at the forefront of animal-human transplantation compared notes and allowed themselves the first real optimism in decades.
Leah Stavenhagen, now 32, started Her A.L.S. Story in 2021, two years after she herself was diagnosed with A.L.S., because she wanted to connect with other young women with the disease. A BiPAP machine helps her breathe.
Doctors have already begun reducing radiation treatment for women at low risk of recurrence or spread of the disease. A new study finds that some women at greater risk can safely avoid radiation.
Researchers followed 1,600 women for a median of 9.6 years and found that survival rates were similar in two groups of patients: 81.4 percent among the patients who had received radiation treatment and 81.9 percent among those who had not.